Trending News Today: White House Releases First Steps to Lower Drug Costs

On Friday, the White House released a 30-page white paper outlining strategies to lower drug costs through reforms to Medicare and Medicaid. The plan, which also seeks to expedite drug approvals while spurring innovation and competition, was met with mixed reviews. "Despite promises to drastically lower prices, the mix of proposed changes does not appear likely to do so, even though there are some constructive proposals," John Rother, CEO of the advocacy group National Coalition on Health Care, told ABC News. The proposal includes measures such as reviving Medicaid rules to remove incentivizes for manufacturers to inflate drug costs, requiring insurers to share manufacturer drug rebates with patients, and altering the rule that requires the Medicare prescription program to cover at least 2 different medications across each drug class, according to ABC News. "And prices will come down substantially," President Donald Trump said in the ABC report. "Watch."
The number of patients in the United States infected with a rare, deadly superbug recently reached 200, up from only 7 infections reported in 2016, according to Kaiser Health News. Candida auris typically enters the bloodstream through wounds, ventilators, or catheters and leaves patients whose health is compromised especially at risk, specifically those in hospitals and long-term care facilities, according to Kaiser. The report notes that C. auris, which acts similarly to a bacterial superbug, is easily transmitted through contact with contaminated surfaces or person to person. Approximately 40% of those infected with the bacteria have died. The current outbreak has mainly been centered in New York and New Jersey, with cases also reported in California, Illinois, and Florida, according to Kaiser.
President Trump’s budget proposal will include approximately $17 billion to combat the opioid epidemic, according to The Hill. The Department of Health and Human Services will receive $3 billion in 2018 and $10 billion for 2019 to expand prevention, treatment, recovery, and mental health services, The Hill reported. The funding follows Trump’s declaration of the epidemic as a public health emergency months ago.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Most Popular

Related Articles

Specialty therapies for autoimmune diseases and cancer topped the list of biggest-selling drugs for 2018.
A data-centric approach is vital for patients with complex conditions, particularly in determining what has worked well and anticipating what medical or pharmacy care is required for effective outcomes in the future.
The shift from fee-based, volume-driven care to value-based, patient-centered care and the growth of specialty pharmaceuticals are propelling us all into uncharted territory, no matter what role you play in health care.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.